PMV Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
PMV Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • PMV Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $12K, a 90.6% decline year-over-year.
  • PMV Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $35.6M, a 3614% increase from 2022.
  • PMV Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $958K, a 52.6% decline from 2021.
  • PMV Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.02M, a 99.3% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $35.6M +$34.6M +3614% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $958K -$1.06M -52.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $2.02M -$291M -99.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $293M +$231M +374% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $61.8M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.